This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Analysts' Actions: ABX DGX HRC IBM ISRG


Barrick Gold (ABX - Get Report) was downgraded at Stifel Nicolaus to hold from buy. Company will be hurt by lower gold prices, Stifel Nicolaus said.

Addvantage Technologies (AEY) was downgraded to hold at TheStreet Ratings.

Acuity Brands (AYI) was downgraded at Canaccord Genuity to hold. $78 price target. Company still exhibits strong fundamentals and rising market share, but has reached its valuation limit, Canaccord Genuity said.

Convergys (CVG) was upgraded at Goldman Sachs to neutral from sell. $18 price target. Company can expand its margins, Goldman said.

Quest Diagnostics (DGX - Get Report) was downgraded at Morgan Stanley to underweight from equal-weight. Price target is $58. Cuts to physician fee schedule will negatively impact future earnings, Morgan Stanley said.

[Read: <a target="blank" data-add-tracking="true" href=""><em>Kass: Housing Faces a Credit Event</em></a>]

Glatfelter (GLT) was downgraded at Deutsche Bank to hold from buy. Valuation call, based on a $26 price target, Deutsche said.

Gentex (GNTX) was downgraded at Robert Baird to neutral from outperform. Valuation call, Baird said.

Helmerich & Payne (HP) was downgraded at Jefferies to hold from buy. $71 price target. Industry will likely face higher CapEx budgets, Jefferies said.

Hill-Rom Holdings (HRC) was downgraded at Goldman Sachs to neutral from buy. $36 price target. Thesis will take longer to materialize than initially anticipated, Goldman said.

Fresh Market (TFM) was upgraded to buy at TheStreet Ratings.

IBM (IBM - Get Report) was downgraded at Goldman Sachs to neutral from buy. $200 price target. Key markets may face increased pressure in the coming quarters, Goldman said.

[Read: <a target="blank" data-add-tracking="true" href=""><em>Amarin's Stock Sale Helps Shorts Cover Winning Trade</em></a>]

Intuitive Surgical (ISRG - Get Report) was downgraded at Goldman Sachs to neutral from buy. $500 price target. Following preannouncement, upside case increasingly challenged, Goldman said.

Intuitive Surgical was downgraded at Canaccord Genuity to hold. $444 price target. Confusion concerning contractions in ISRG's system placement business have widened disparity amongst consensus estimates, Canaccord Genuity said.

Intuitive Surgical was downgraded at JMP Securities to market perform after failing to meet second-quarter estimates. Future estimates were also lowered.

Kapstone Paper (KS) was downgraded at Deutsche Bank to sell from hold. $38 price target. Valuation call, as the company trades at a premium to its peers, Deutsche Bank said.
1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
ABX $19.37 0.00%
DGX $75.17 0.00%
IBM $145.94 0.00%
HRC $48.35 0.00%
ISRG $626.36 0.00%


Chart of I:DJI
DOW 17,773.64 -57.12 -0.32%
S&P 500 2,065.30 -10.51 -0.51%
NASDAQ 4,775.3580 -29.9330 -0.62%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs